CVS common stock trading at a P/E of 9.7; stock price at 5yr low. 2017 revenue growth was +4.1%, down from 5yr CAGR of +10.7%. Amazon consortium apparently not an imminent threat. M&A of Aetna may provide catalyst for a new …
NEEDHAM, Mass., March 27, 2018 /PRNewswire/ -- CVS Pharmacy has selected ZymaDerm™, the most widely used …
Amazon has made indications it would be moving into drug delivery, affecting CVS, Walgreens and Express Scripts’ models ... are working internationally versus in the States. While stock prices dropped immediately, details are still …
CVS Pharmacy has selected ZymaDerm™, the most widely used topical treatment product for molluscum …